Insulin Delivery Pens Market by Product, Technology, Distribution Channel, & Region | Forecast 2022 to 2032
Can Signing of New Contracts and Launch of Novel Products Generate Revenue for Insulin Delivery Pens Manufacturers? Get Exclusive Details in FMI's Study!
Insulin Delivery Pens Market Outlook (2022 to 2032)
The global insulin delivery pens market is expected to reach a valuation of US$ 22.4 Billion by the end of 2022, and further expand at a CAGR of 8.0% to reach a valuation of US$ 48.6 Billion by the end of 2032. According to a recent study by Future Market Insights, smart insulin pens by-products are leading the market and held a share of about 34.6% in the year 2021.
Diabetes management frequently necessitates taking insulin shots throughout the day. Insulin delivery technologies such as insulin pens can make it considerably easier to administer insulin shots. The usage of a vial and syringe to give insulin can be replaced with an insulin pen, making diabetes management easier for patients. Insulin pens do not eliminate the necessity for needle pricks. They simply make measuring and administering insulin easier.
Insulin pens can give between 0.5 and 80 units of insulin at a time. They can deliver insulin in half-unit, one-unit, or two-unit intervals. The maximum dose and incremental amount differ between pens. The overall number of insulin units in the cartridges varies as well. Insulin pens are a practical way to control one’s levels of blood sugar. Insulin pens are compact and portable, containing medicine and a syringe packed within one device, making them a perfect solution for individuals on the go.
In addition, diabetes is a leading cause of kidney failure, blindness, heart attacks, amputation of lower limbs, and stroke. Diabetes-related premature mortality increased by 5% between 2000 and 2016. Regular physical activity, a nutritious diet, maintaining a normal body weight, and moving away from tobacco use are all approaches to avoiding or postponing the onset of type 2 diabetes. Thus, owing to the aforementioned factors, the global insulin delivery pens market is expected to grow at a CAGR of 8.0% during the forecast period from 2022 to 2032.
However, individual insulin pens stored or distributed outside of their box pose an increased risk of dispensing errors and patients using the wrong substance. Individually delivered insulin pens outside of their boxes may have contributed to medication errors such as wrong-dose and wrong-drug errors, thereby resulting in hyperglycaemia or hypoglycaemia, missing doses, allegations of potential tampering, and delivery without directions for the usage which may lead to hindrance for the market to grow. These factors are anticipated to negatively impact the insulin delivery pens market.
Apart from that, several companies are nowadays participating in mergers & acquisitions and collaborations & partnerships with local players to compete with their rivals. In October 2022, BIOCORP, a leading manufacturer of unique medical devices based in France, joined hands with Merck KGaA, a Germany-based technology company, to create and supply a specific version of Mallya device as an important accessory for one of Merck KGaA’s drug delivery devices.
Moreover, in March 2022, Novo Nordisk introduced its latest smart insulin pens in the United Kingdom to provide National Health Service (NHS) diabetes patients with the ability to monitor and note dosing information. The company is aiming to compete with its rivals, namely, Sanofi and Eli Lilly in the highly competitive insulin sector.
Attributes
Key Insights
Global Insulin Delivery Pens Market Estimated Size (2022E)
US$ 22.4 Billion
Projected Market Valuation (2032F)
US$ 48.6 Billion
Value-based CAGR (2022 to 2032)
8.0%
Collective Value Share: Top 5 Countries
57.4%
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
2014 to 2021 Global Insulin Delivery Pens Market Outlook Compared to 2022 to 2032 Demand Forecast
The global insulin delivery pens market held approximately 3.3% of the global injectable drug delivery market, which was worth US$ 624.5 Billion in 2021. Sales of insulin delivery pens expanded at a CAGR of 6.5% from 2014 to 2021.
Insulin pens are becoming increasingly popular, and many diabetics nowadays use a pen to inject insulin. These pens make insulin delivery easier, more accurate, and more convenient than a vial or syringe. Not everyone with diabetes will require insulin, especially those who do discover that adhering to an insulin schedule can be hard, disruptive, and depleting. Some patients prefer insulin pens to make insulin administration less obtrusive and cumbersome. Demand in the insulin pen market will be boosted in the next decade as the prevalence of diabetes is on the rise.
The World Health Organization (WHO) in November 2021, stated that diabetes is a long-term condition that develops when the pancreas is unable to produce sufficient insulin or when the body fails to adequately utilize the insulin that is produced. Hyperglycaemia or high blood sugar is a typical side effect of untreated diabetes, and it can cause some serious harm to many of the body functions, particularly the neurons and blood vessels, over time. Hyperglycaemia impacted 8.5% of individuals aged 18 and up in 2014. Diabetes was the primary consequence of 1.5 million fatalities in 2019, with 48% of all diabetes-related mortalities before the age of 70. are frequently more expensive than a vial of insulin. If the gadget must be primed before injection, some insulin is squandered. Access to life-saving medication is a luxury that many people in the USA cannot afford.
Soaring drug prices and insufficient health insurance coverage can result in unpayable out-of-pocket expenses, undermining the right to health, driving people into financial distress & debt, and disproportionately affecting people who are socially and economically marginalized, reinforcing existing forms of structural discrimination.
For instance, a box of five Humalog KwikPens can cost more than $600 depending on a person’s insurance and the drugstore one visits, while the recently available authorized generic can cost more than $300. Each pen is filled with 3 mL of insulin. Admelog prices vary by the drug store, but a box of five 3-mL insulin-prefilled pens costs around $150.
Top Trends Fostering Sales in the Insulin Delivery Pens Market
Development of Smart Insulin Caps to Bode Well for Insulin Delivery Pens Manufacturers
The market is likely to provide an opportunistic perspective owing to initiatives by governments in emerging countries that are engaging significantly in healthcare infrastructure development, which is expected to broaden access to healthcare services. It is further expected to boost demand for better technologies, creating an appealing opportunity in the global insulin delivery pens market.
Technological developments and the use of innovative designs that are chosen over traditional insulin administration techniques such as syringes and needles would push the market. Insulin pens are supporting smartphone and internet technologies, which would speed up and improve the accuracy of the administration process.
Emerging market participants are working on developing enhanced gadgets such as smart pens and smart insulin caps that can be connected via mobile technologies. Because of the internet's significance, e-commerce has grown in terms of popularity in recent years.
Furthermore, due to social distancing regulations, the COVID-19 pandemic has produced a scenario in which e-commerce is mainly preferred. As a result, the online availability of diabetes management solutions would provide significant market growth prospects.
Find your sweet spots for generating winning opportunities in this market.
What are the Factors Restraining the Demand for Insulin Delivery Pens?
The rising cost and how technology advances in the healthcare field can hamper growth in the insulin delivery pens market during the forecast period. Insulin pens are frequently more expensive than a vial of insulin. If the gadget must be primed before injection, some insulin is squandered. Access to life-saving medication is a luxury that many people in the USA cannot afford.
Soaring drug prices and insufficient health insurance coverage can result in unpayable out-of-pocket expenses, undermining the right to health, driving people into financial distress & debt, and disproportionately affecting people who are socially and economically marginalized, reinforcing existing forms of structural discrimination.
For instance, a box of five Humalog KwikPens can cost more than $600 depending on a person’s insurance and the drugstore one visits, while the recently available authorized generic can cost more than $300. Each pen is filled with 3 mL of insulin. Admelog prices vary by the drug store, but a box of five 3-mL insulin-prefilled pens costs around $150.
Country-wise Insights
Why is the USA Set to Remain at the Forefront in the Field of Insulin Delivery Pens?
High Prevalence of Hyperglycaemia in the U.S. to Fuel Sales of Insulin Syringes
The USA dominated the North American region with a total market share of over 80% in 2021 and is expected to continue to experience promising growth throughout the forecast period. According to Human Rights Watch 2018, about 27 million adults in the United States were diagnosed with diabetes, and roughly 8.2 million adults used one or more insulin formulations to control their blood sugar. People who require insulin may have hyperglycaemia or high blood sugar, which can lead to significant and even life-threatening consequences. It is anticipated to push growth in the insulin pen market in the USA in the coming decade.
Why Are Insulin Delivery Pens Manufacturers Exhibiting Lucrative Growth in China?
Patients with Inadequate Glycaemic Control in China to Use Reusable Insulin Pen Devices
China held approximately 54% of the share in the East Asia insulin delivery pens market in 2021 and is likely to witness growth at a lucrative CAGR of 10.1% during the forecast period. According to the International Diabetes Federation’s (IDF) Diabetes Atlas 2018, China has the world's highest diabetes population of 109.6 million, which is imposing a significant healthcare burden on society.
Diabetes is inadequately managed in China, with less than half of individuals diagnosed achieving the HbA1c goal threshold of 7.0% (53 mmol/mol). Insulin is indicated in both national and international diabetes care guidelines for patients with inadequate glycaemic control who are receiving oral antihyperglycemic medications.
What is the Outlook of Germany in the Insulin Delivery Pens Industry?
Availability of Bluetooth-enabled Insulin Injection Pens to Drive Growth in Germany
Germany is set to exhibit a CAGR of nearly 9.3% in the Europe insulin delivery pens market during the forecast period. Emperra GmbH, which is based in Germany, launched its first Bluetooth insulin pen in August 2016. Emperra is thus the only firm that can reach individuals with diabetes of all ages through a holistic creative strategy of digital solutions with smart insulin pens. As a result, the greatest community of older type 2 diabetics on insulin is being digitally accessed for the first time in Germany.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need and save 40%!
Category-wise Insights
Which is the Highly Preferred Insulin Delivery Pen across the Globe?
Smart Ultra Fine Pen Needles to Gain Impetus with Their Ability to Prevent Skipped Doses
Smart insulin pens are expected to showcase high growth at a CAGR of 6.3% by the end of the forecast period. The segment had captured nearly one-third of the share in the global market in 2021 owing to various beneficial factors like the provision of precise half-unit doses, assisting in preventing missing or skipped doses, and notifications on how to treat a high blood sugar readings, keeping track of the duration & dosage of each administration, and set a reminder for the next one.
Which Technology is Trending in the Space of Insulin Delivery Pens?
Diabetic Pen Needles with Non-smart Injectors to Witness Immense Popularity by 2032
Non-smart injectors held a revenue share of nearly 84.6% in 2021 and are expected to witness steady growth in the insulin delivery pens market over the forecast period. Non-smart insulin injectors can provide several shots as they are pre-filled and allow for accurate dosing. This factor is expected to fuel the revenue growth of the segment over the forecast period.
Which Distribution Channel are Consumers Choosing to Purchase Insulin Delivery Pens?
Demand for Insulin Needles For Pens to Surge among Hospital Pharmacies Worldwide
Hospital pharmacies held the highest insulin delivery pens market share of over 35% in 2021. Increasing inpatient admissions and easy prescription-based medicines provided at hospital pharmacies are propelling sales of the overall insulin delivery pens market.
Competitive Landscape
There are several competitors in the global insulin delivery pens market. To meet the rising consumer demand and expand their customer base, these companies are implementing various strategies such as mergers & acquisitions, partnerships & collaborations, and new product launches.
Some of the recent developments by key players in the insulin delivery pens market are given below:
In August 2019, Enable Injections, Inc. (Enable), a business developing and producing investigational wearable infusion devices for combination products, announced that it has entered into a development agreement with Genentech, a Roche Group subsidiary. Enable's enFuse will enable patient-administered subcutaneous delivery of high-volume medicines.
In October 2019, West Pharmaceutical Services, Inc. launched ovaPure 3mL Cartridge components and SmartDose Gen. II 10mL injector at the 2019 PDA Universe of Pre-Filled Syringes and Injection Devices (PDA PFS).
Scope of the Insulin Delivery Pens Market Report
Attribute
Details
Estimated Market Size (2022)
US$ 22424.7 Million
Projected Market Valuation (2032)
US$ 48626.3 Million
Value-based CAGR (2022 to 2032)
8.0%
Forecast Period
2014 to 2021
Historical Data Available for
2022 to 2032
Market Analysis
Value (US$ Million)
Key Regions Covered
North America, Latin America, Europe, South Asia, East Asia, Oceania, and Middle East & Africa
Key Countries Covered
USA, Canada, Brazil, Mexico, Argentina, United Kingdom, Germany, Italy, Russia, Spain, France, BENELUX, Nordic Countries, India, Thailand, Indonesia, Malaysia, Japan, China, South Korea, Australia, New Zealand, Turkey, GCC Countries, South Africa, and North Africa
Key Market Segments Covered
Product, Technology, Distribution Channel, and Region
Key Companies Profiled
Eli Lilly and Company
Becton, Dickinson & Company
West Pharmaceutical Services, Inc
Johnson & Johnson
Antares Pharma
AbbVie Inc.
Pfizer Inc
Mylan N.V
Vetter Pharma-Fertigung GmbH & Co.KG
Emperra GmbH
Digital Medics Pty Ltd
Enable Injections LLC
Insulet Corporation
Consort Medical Plc
Diabnext
Diamesco Co., Ltd
SCHOTT AG
SiO2 Medical Products
Integrity Bio, Inc.
Wilhelm Haselmeier GmbH & Co. KG
Tandem Diabetes Care
Sanofi S.A.
Companion Medical Inc.
Ypsomed
Hoffman - La Roche Ltd
Novo Nordisk A/S
Medtronic Plc.
Norgen Biotek Corp.
Omega Diagnostics Group Plc.
Qiagen N.V.
Quidel Corporation,
Thermo Fisher Scientific Inc.
Report Coverage
Market Forecast, Company Share Analysis, Competition Intelligence, Drivers, Restraints, Opportunities and Threats Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives
Key Segments Covered in Insulin Delivery Pens Market Report
How much is the insulin delivery pens market estimated to be worth in 2022?
The global insulin delivery pens market is estimated to be worth US$ 22.4 Billion in 2021 and is set to expand 2.2x over the next ten years.
What is the sales forecast for the insulin delivery pens market through 2032?
The insulin delivery pens market is expected to reach US$ 48.6 Billion by the end of 2032, with sales revenue anticipated to register an 8.0% CAGR.
What are the key trends shaping the insulin delivery pens industry?
The growing prevalence of diabetes, innovative product development, and increasing adoption of insulin pens are some of the key trends in the insulin delivery pens market.
Which are the top five countries driving demand for insulin delivery pens?
The USA, India, China, Germany, and Japan are expected to drive demand in the insulin delivery pens market.
What is the North America insulin delivery pens market outlook?
North America is one of the key markets for insulin delivery pens, with the USA accounting for about 84.8% of the North America insulin delivery pens market in 2021
At what percentage is the demand for insulin delivery pens expected to register growth in Europe?
Demand for insulin delivery pens in Europe is expected to register growth at a CAGR of 7.8% over the next ten years.
At what CAGR is the insulin delivery pens market expected to register growth in Latin America?
Demand for insulin delivery pens in Latin America is expected to register a CAGR of 7.6% over the next ten years
Which countries are the key producers of insulin delivery pens?
China, the USA, and Germany are the key producers of insulin delivery pens.
Who are the key players in the insulin delivery pens market?
Eli Lilly and Company, Becton, Dickinson & Company, West Pharmaceutical Services, Inc, Johnson & Johnson, Antares Pharma, AbbVie Inc., Pfizer Inc, Mylan N.V, Vetter Pharma-Fertigung GmbH & Co.KG, Emperra GmbH, Digital Medics Pty Ltd, Enable Injections LLC, Insulet corporation, Consort Medical Plc, Diabnext, and Medtronic Plc are some of the key players in the insulin delivery pens market.
Table of Content
1. Executive Summary | Insulin Delivery Pens Market
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Technology Roadmap
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends
4. Key Success Factors
4.1. Disease Epidemiology
4.2. Patient Journey
4.3. Regulatory Scenario
4.4. Reimbursement Landscape
4.5. PESTEL analysis
4.6. Porter’s analysis
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global GDP Growth Outlook
5.1.2. Global Healthcare GDP Growth Overview
5.1.3. Global Drug Delivery Market Overview
5.2. Forecast Factors - Relevance & Impact
5.2.1. Rising prevalence of Diabetic cases.
5.2.2. Increasing awareness and adoption of Insulin Delivery Pen.
5.2.3. New Product Launches
5.2.4. Advancing medical technology and developments of Insulin Delivery Pen.
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. COVID-19 Crisis - Crisis Analysis
6.1. COVID-19 and Impact Analysis
6.1.1. By Product
6.1.2. By Technology
6.1.3. By Distribution Channel
6.1.4. By Region
6.2. 2021 Market Scenario
7. Global Market Volume (Units) Analysis 2014 to 2021 and Forecast, 2022 to 2032
7.1. Historical Market Volume (Units) Analysis, 2014 to 2021
7.2. Current and Future Market Volume (Units) Projections, 2022 to 2032
7.2.1. Y-o-Y Growth Trend Analysis
8. Global Market - Pricing Analysis
8.1. Regional Pricing Analysis By Product
8.2. Pricing Break-up
8.2.1. Manufacturer-Level Pricing
8.2.2. Distributor Level Pricing
8.3. Global Average Pricing Analysis Benchmark
8.4. Pricing Assumptions
9. Global Market Demand (in Value or Size in US$ Million) Analysis 2014 to 2021 and Forecast, 2022 to 2032
9.1. Historical Market Value (US$ Million) Analysis, 2014 to 2021
9.2. Current and Future Market Value (US$ Million) Projections, 2022 to 2032
9.2.1. Y-o-Y Growth Trend Analysis
9.2.2. Absolute $ Opportunity Analysis
10. Global Market Analysis 2014 to 2021 and Forecast 2022 to 2032, by Product
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Product, 2014 to 2021
10.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Product, 2022 to 2032
10.3.1. Reusable Insulin Pens
10.3.2. Disposable Insulin Pens
10.3.3. Smart Insulin Pens
10.4. Market Attractiveness Analysis By Product
11. Global Market Analysis 2014 to 2021 and Forecast 2022 to 2032, by Technology
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Million) Analysis By Technology, 2014 to 2021
11.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Technology, 2022 to 2032
11.3.1. Non-Smart Injectors
11.3.2. Smart Injectors
11.3.2.1. Artificial Intelligence (AI) & Machine Learning Integrated
11.3.2.2. Near Field Communication(NFR)
11.3.2.3. Cloud Computing
11.3.2.4. Bluetooth
11.4. Market Attractiveness Analysis By Technology
12. Global Market Analysis 2014 to 2021 and Forecast 2022 to 2032, by Distribution Channel
12.1. Introduction / Key Findings
12.2. Historical Market Size (US$ Million) Analysis, By Distribution Channel, 2014 to 2021
12.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Distribution Channel, 2022 to 2032
12.3.1. Hospital Pharmacies
12.3.2. Drug Stores
12.3.3. Retail Pharmacies
12.3.4. Online Pharmacies
12.4. Market Attractiveness Analysis By Distribution Channel
13. Global Market Analysis 2014 to 2021 and Forecast 2022 to 2032, by Region
13.1. Introduction
13.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Region, 2014 to 2021
13.3. Current Market and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Region, 2022 to 2032
13.3.1. North America
13.3.2. Latin America
13.3.3. Europe
13.3.4. East Asia
13.3.5. South Asia
13.3.6. Oceania
13.3.7. Middle East and Africa (MEA)
13.4. Market Attractiveness Analysis By Region
14. North America Market Analysis 2014 to 2021 and Forecast 2022 to 2032
14.1. Introduction
14.2. Pricing Analysis
14.3. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis By Market Taxonomy, 2014 to 2021
14.4. Current and Future Market Size (US$ Million) and Volume (Units) Forecast By Market Taxonomy, 2022 to 2032
14.4.1. By Country
14.4.1.1. USA
14.4.1.2. Canada
14.4.2. By Product
14.4.3. By Technology
14.4.4. By Distribution Channel
14.5. Market Attractiveness Analysis
14.5.1. By Country
14.5.2. By Product
14.5.3. By Technology
14.5.4. By Distribution Channel
14.6. Market Trends
14.7. Key Market Participants - Intensity Mapping
14.8. Drivers and Restraints - Impact Analysis
14.9. Country-Level Analysis & Forecast
14.9.1. USA Market Analysis
14.9.1.1. .Introduction
14.9.1.2. Market Analysis and Forecast by Market Taxonomy
14.9.1.2.1. By Product
14.9.1.2.2. By Technology
14.9.1.2.3. By Distribution Channel
14.9.2. Canada Market Analysis
14.9.2.1. Introduction
14.9.2.2. Market Analysis and Forecast by Market Taxonomy
14.9.2.2.1. By Product
14.9.2.2.2. By Technology
14.9.2.2.3. By Distribution Channel
15. Latin America Market Analysis 2014 to 2021 and Forecast 2022 to 2032
15.1. Introduction
15.2. Pricing Analysis
15.3. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis By Market Taxonomy, 2014 to 2021
15.4. Current and Future Market Size (US$ Million) and Volume (Units) Forecast By Market Taxonomy, 2022 to 2032
15.4.1. By Country
15.4.1.1. Mexico
15.4.1.2. Brazil
15.4.1.3. Argentina
15.4.1.4. Rest of Latin America
15.4.2. By Product
15.4.3. By Technology
15.4.4. By Distribution Channel
15.5. Market Attractiveness Analysis
15.5.1. By Country
15.5.2. By Product
15.5.3. By Technology
15.5.4. By Distribution Channel
15.6. Market Trends
15.7. Key Market Participants - Intensity Mapping
15.8. Drivers and Restraints - Impact Analysis
15.9. Country-Level Analysis & Forecast
15.9.1. Mexico Market Analysis
15.9.1.1. Introduction
15.9.1.2. Market Analysis and Forecast by Market Taxonomy
15.9.1.2.1. By Product
15.9.1.2.2. By Technology
15.9.1.2.3. By Distribution Channel
15.9.2. Brazil Market Analysis
15.9.2.1. Introduction
15.9.2.2. Market Analysis and Forecast by Market Taxonomy
15.9.2.2.1. By Product
15.9.2.2.2. By Technology
15.9.2.2.3. By Distribution Channel
15.9.3. Argentina Market Analysis
15.9.3.1. Introduction
15.9.3.2. Market Analysis and Forecast by Market Taxonomy
15.9.3.2.1. By Product
15.9.3.2.2. By Technology
15.9.3.2.3. By Distribution Channel
16. Europe Market Analysis 2014 to 2021 and Forecast 2022 to 2032
16.1. Introduction
16.2. Pricing Analysis
16.3. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis By Market Taxonomy, 2014 to 2021
16.4. Current and Future Market Size (US$ Million) and Volume (Units) Forecast By Market Taxonomy, 2022 to 2032
16.4.1. By Country
16.4.1.1. Germany
16.4.1.2. Italy
16.4.1.3. France
16.4.1.4. United Kingdom
16.4.1.5. Spain
16.4.1.6. BENELUX
16.4.1.7. Russia
16.4.1.8. Rest of Europe
16.4.2. By Product
16.4.3. By Technology
16.4.4. By Distribution Channel
16.5. Market Attractiveness Analysis
16.5.1. By Country
16.5.2. By Product
16.5.3. By Technology
16.5.4. By Distribution Channel
16.6. Market Trends
16.7. Key Market Participants - Intensity Mapping
16.8. Drivers and Restraints - Impact Analysis
16.9. Country-Level Analysis & Forecast
16.9.1. Germany Market Analysis
16.9.1.1. Introduction
16.9.1.2. Market Analysis and Forecast by Market Taxonomy
16.9.1.2.1. By Product
16.9.1.2.2. By Technology
16.9.1.2.3. By Distribution Channel
16.9.2. Italy Market Analysis
16.9.2.1. Introduction
16.9.2.2. Market Analysis and Forecast by Market Taxonomy
16.9.2.2.1. By Product
16.9.2.2.2. By Technology
16.9.2.2.3. By Distribution Channel
16.9.3. France Market Analysis
16.9.3.1. Introduction
16.9.3.2. Market Analysis and Forecast by Market Taxonomy
16.9.3.2.1. By Product
16.9.3.2.2. By Technology
16.9.3.2.3. By Distribution Channel
16.9.4. United Kingdom Market Analysis
16.9.4.1. Introduction
16.9.4.2. Market Analysis and Forecast by Market Taxonomy
16.9.4.2.1. By Product
16.9.4.2.2. By Technology
16.9.4.2.3. By Distribution Channel
16.9.5. Spain Market Analysis
16.9.5.1. Introduction
16.9.5.2. Market Analysis and Forecast by Market Taxonomy
16.9.5.2.1. By Product
16.9.5.2.2. By Technology
16.9.5.2.3. By Distribution Channel
16.9.6. BENELUX Market Analysis
16.9.6.1. Introduction
16.9.6.2. Market Analysis and Forecast by Market Taxonomy
16.9.6.2.1. By Product
16.9.6.2.2. By Technology
16.9.6.2.3. By Distribution Channel
16.9.7. Russia Market Analysis
16.9.7.1. Introduction
16.9.7.2. Market Analysis and Forecast by Market Taxonomy
16.9.7.2.1. By Product
16.9.7.2.2. By Technology
16.9.7.2.3. By Distribution Channel
17. South Asia Market Analysis 2014 to 2021 and Forecast 2022 to 2032
17.1. Introduction
17.2. Pricing Analysis
17.3. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis By Market Taxonomy, 2014 to 2021
17.4. Current and Future Market Size (US$ Million) and Volume (Units) Forecast By Market Taxonomy, 2022 to 2032
17.4.1. By Country
17.4.1.1. India
17.4.1.2. Indonesia
17.4.1.3. Malaysia
17.4.1.4. Thailand
17.4.1.5. Rest of South Asia
17.4.2. By Product
17.4.3. By Technology
17.4.4. By Distribution Channel
17.5. Market Attractiveness Analysis
17.5.1. By Country
17.5.2. By Product
17.5.3. By Technology
17.5.4. By Distribution Channel
17.6. Market Trends
17.7. Key Market Participants - Intensity Mapping
17.8. Drivers and Restraints - Impact Analysis
17.9. Country-Level Analysis & Forecast
17.9.1. India Market Analysis
17.9.1.1. Introduction
17.9.1.2. Market Analysis and Forecast by Market Taxonomy
17.9.1.2.1. By Product
17.9.1.2.2. By Technology
17.9.1.2.3. By Distribution Channel
17.9.2. Indonesia Market Analysis
17.9.2.1. Introduction
17.9.2.2. Market Analysis and Forecast by Market Taxonomy
17.9.2.2.1. By Product
17.9.2.2.2. By Technology
17.9.2.2.3. By Distribution Channel
17.9.3. Malaysia Market Analysis
17.9.3.1. Introduction
17.9.3.2. Market Analysis and Forecast by Market Taxonomy
17.9.3.2.1. By Product
17.9.3.2.2. By Technology
17.9.3.2.3. By Distribution Channel
17.9.4. Thailand Market Analysis
17.9.4.1. Introduction
17.9.4.2. Market Analysis and Forecast by Market Taxonomy
17.9.4.2.1. By Product
17.9.4.2.2. By Technology
17.9.4.2.3. By Distribution Channel
18. East Asia Market Analysis 2014 to 2021 and Forecast 2022 to 2032
18.1. Introduction
18.2. Pricing Analysis
18.3. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis By Market Taxonomy, 2014 to 2021
18.4. Current and Future Market Size (US$ Million) and Volume (Units) Forecast By Market Taxonomy, 2022 to 2032
18.4.1. By Country
18.4.1.1. China
18.4.1.2. Japan
18.4.1.3. South Korea
18.4.2. By Product
18.4.3. By Technology
18.4.4. By Distribution Channel
18.5. Market Attractiveness Analysis
18.5.1. By Country
18.5.2. By Product
18.5.3. By Technology
18.5.4. By Distribution Channel
18.6. Market Trends
18.7. Key Market Participants - Intensity Mapping
18.8. Drivers and Restraints - Impact Analysis
18.9. Country-Level Analysis & Forecast
18.9.1. China Market Analysis
18.9.1.1. Introduction
18.9.1.2. Market Analysis and Forecast by Market Taxonomy
18.9.1.2.1. By Product
18.9.1.2.2. By Technology
18.9.1.2.3. By Distribution Channel
18.9.2. Japan Market Analysis
18.9.2.1. Introduction
18.9.2.2. Market Analysis and Forecast by Market Taxonomy
18.9.2.2.1. By Product
18.9.2.2.2. By Technology
18.9.2.2.3. By Distribution Channel
18.9.3. South Korea Market Analysis
18.9.3.1. Introduction
18.9.3.2. Market Analysis and Forecast by Market Taxonomy
18.9.3.2.1. By Product
18.9.3.2.2. By Technology
18.9.3.2.3. By Distribution Channel
19. Oceania Market 2017 to 2021 and Forecast 2022 to 2032
19.1. Introduction
19.2. Pricing Analysis
19.3. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis By Market Taxonomy, 2014 to 2021
19.4. Current and Future Market Size (US$ Million) and Volume (Units) Forecast By Market Taxonomy, 2022 to 2032
19.4.1. By Country
19.4.1.1. Australia
19.4.1.2. New Zealand
19.4.2. By Product
19.4.3. By Technology
19.4.4. By Distribution Channel
19.5. Market Attractiveness Analysis
19.5.1. By Country
19.5.2. By Product
19.5.3. By Technology
19.5.4. By Distribution Channel
19.6. Key Market Participants - Intensity Mapping
19.7. Drivers and Restraints - Impact Analysis
19.8. Country-Level Analysis & Forecast
19.8.1. Australia Market Analysis
19.8.1.1. Introduction
19.8.1.2. Market Analysis and Forecast by Market Taxonomy
19.8.1.2.1. By Product
19.8.1.2.2. By Technology
19.8.1.2.3. By Distribution Channel
19.8.2. New Zealand Market Analysis
19.8.2.1. Introduction
19.8.2.2. Market Analysis and Forecast by Market Taxonomy
19.8.2.2.1. By Product
19.8.2.2.2. By Technology
19.8.2.2.3. By Distribution Channel
20. Middle East and Africa (MEA) Market Analysis 2014 to 2021 and Forecast 2022 to 2032
20.1. Introduction
20.2. Pricing Analysis
20.3. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis By Market Taxonomy, 2014 to 2021
20.4. Current and Future Market Size (US$ Million) and Volume (Units) Forecast By Market Taxonomy, 2022 to 2032
20.4.1. By Country
20.4.1.1. GCC Countries
20.4.1.2. Turkey
20.4.1.3. South Africa
20.4.1.4. North Africa
20.4.1.5. Rest of Middle East and Africa
20.4.2. By Product
20.4.3. By Technology
20.4.4. By Distribution Channel
20.5. Market Attractiveness Analysis
20.5.1. By Country
20.5.2. By Product
20.5.3. By Technology
20.5.4. By Distribution Channel
20.6. Market Trends
20.7. Key Market Participants - Intensity Mapping
20.8. Drivers and Restraints - Impact Analysis
20.9. Country-Level Analysis & Forecast
20.9.1. GCC Countries Market Analysis
20.9.1.1. Introduction
20.9.1.2. Market Analysis and Forecast by Market Taxonomy
20.9.1.2.1. By Product
20.9.1.2.2. By Technology
20.9.1.2.3. By Distribution Channel
20.9.2. Turkey Market Analysis
20.9.2.1. Introduction
20.9.2.2. Market Analysis and Forecast by Market Taxonomy
20.9.2.2.1. By Product
20.9.2.2.2. By Technology
20.9.2.2.3. By Distribution Channel
20.9.3. South Africa Market Analysis
20.9.3.1. Introduction
20.9.3.2. Market Analysis and Forecast by Market Taxonomy
20.9.3.2.1. By Product
20.9.3.2.2. By Technology
20.9.3.2.3. By Distribution Channel
20.9.4. North Africa Market Analysis
20.9.4.1. Introduction
20.9.4.2. Market Analysis and Forecast by Market Taxonomy
20.9.4.2.1. By Product
20.9.4.2.2. By Technology
20.9.4.2.3. By Distribution Channel
21. Market Structure Analysis
21.1. Market Analysis by Tier of Companies
21.2. Market Share Analysis of Top Players
21.3. Market Presence Analysis
22. Competition Analysis
22.1. Competition Dashboard
22.2. Competition Benchmarking
22.3. Competition Deep Dive
22.3.1. Becton, Dickinson, and Company
22.3.1.1. Overview
22.3.1.2. Product Portfolio
22.3.1.3. Sales Footprint
22.3.1.4. SWOT Analysis
22.3.1.5. Key Financials
22.3.1.6. Strategy Overview
22.3.1.7. Eli Lilly and Company Overview
22.3.1.8. Product Portfolio
22.3.1.9. Sales Footprint
22.3.1.10. SWOT Analysis
22.3.1.11. Key Financials
22.3.1.12. Strategy Overview
22.3.2. West Pharmaceutical Services, Inc
22.3.2.1. Overview
22.3.2.2. Product Portfolio
22.3.2.3. Sales Footprint
22.3.2.4. SWOT Analysis
22.3.2.5. Key Financials
22.3.2.6. Strategy Overview
22.3.3. Johnson & Johnson
22.3.3.1. Overview
22.3.3.2. Product Portfolio
22.3.3.3. Sales Footprint
22.3.3.4. SWOT Analysis
22.3.3.5. Key Financials
22.3.3.6. Strategy Overview
22.3.4. Antares Pharma
22.3.4.1. Overview
22.3.4.2. Product Portfolio
22.3.4.3. Sales Footprint
22.3.4.4. SWOT Analysis
22.3.4.5. Key Financials
22.3.4.6. Strategy Overview
22.3.5. AbbVie Inc.
22.3.5.1. Overview
22.3.5.2. Product Portfolio
22.3.5.3. Sales Footprint
22.3.5.4. SWOT Analysis
22.3.5.5. Key Financials
22.3.5.6. Strategy Overview
22.3.6. Pfizer Inc
22.3.6.1. Overview
22.3.6.2. Product Portfolio
22.3.6.3. Sales Footprint
22.3.6.4. SWOT Analysis
22.3.6.5. Key Financials
22.3.6.6. Strategy Overview
22.3.7. Mylan N.V
22.3.7.1. Overview
22.3.7.2. Product Portfolio
22.3.7.3. Sales Footprint
22.3.7.4. SWOT Analysis
22.3.7.5. Key Financials
22.3.7.6. Strategy Overview
22.3.8. Vetter Pharma-Fertigung GmbH & Co.KG
22.3.8.1. Overview
22.3.8.2. Product Portfolio
22.3.8.3. Sales Footprint
22.3.8.4. SWOT Analysis
22.3.8.5. Key Financials
22.3.8.6. Strategy Overview
22.3.9. Emperra GmbH
22.3.9.1. Overview
22.3.9.2. Product Portfolio
22.3.9.3. Sales Footprint
22.3.9.4. SWOT Analysis
22.3.9.5. Key Financials
22.3.9.6. Strategy Overview
22.3.10. Digital Medics Pty Ltd
22.3.10.1. Overview
22.3.10.2. Product Portfolio
22.3.10.3. Sales Footprint
22.3.10.4. SWOT Analysis
22.3.10.5. Key Financials
22.3.10.6. Strategy Overview
22.3.11. Enable Injections LLC
22.3.11.1. Overview
22.3.11.2. Product Portfolio
22.3.11.3. Sales Footprint
22.3.11.4. SWOT Analysis
22.3.11.5. Key Financials
22.3.11.6. Strategy Overview
22.3.12. Insulet corporation
22.3.12.1. Overview
22.3.12.2. Product Portfolio
22.3.12.3. Sales Footprint
22.3.12.4. SWOT Analysis
22.3.12.5. Key Financials
22.3.12.6. Strategy Overview
22.3.13. Consort Medical Plc
22.3.13.1. Overview
22.3.13.2. Product Portfolio
22.3.13.3. Sales Footprint
22.3.13.4. SWOT Analysis
22.3.13.5. Key Financials
22.3.13.6. Strategy Overview
22.3.14. Diabnext
22.3.14.1. Overview
22.3.14.2. Product Portfolio
22.3.14.3. Sales Footprint
22.3.14.4. SWOT Analysis
22.3.14.5. Key Financials
22.3.14.6. Strategy Overview
22.3.15. Diamesco Co., Ltd
22.3.15.1. Overview
22.3.15.2. Product Portfolio
22.3.15.3. Sales Footprint
22.3.15.4. SWOT Analysis
22.3.15.5. Key Financials
22.3.15.6. Strategy Overview
22.3.16. SCHOTT AG
22.3.16.1. Overview
22.3.16.2. Product Portfolio
22.3.16.3. Sales Footprint
22.3.16.4. SWOT Analysis
22.3.16.5. Key Financials
22.3.16.6. Strategy Overview
22.3.17. SiO2 Medical Products
22.3.17.1. Overview
22.3.17.2. Product Portfolio
22.3.17.3. Sales Footprint
22.3.17.4. SWOT Analysis
22.3.17.5. Key Financials
22.3.17.6. Strategy Overview
22.3.18. Integrity Bio, Inc.
22.3.18.1. Overview
22.3.18.2. Product Portfolio
22.3.18.3. Sales Footprint
22.3.18.4. SWOT Analysis
22.3.18.5. Key Financials
22.3.18.6. Strategy Overview
22.3.19. Wilhelm Haselmeier GmbH & Co. KG
22.3.19.1. Overview
22.3.19.2. Product Portfolio
22.3.19.3. Sales Footprint
22.3.19.4. SWOT Analysis
22.3.19.5. Key Financials
22.3.19.6. Strategy Overview
22.3.20. Tandem Diabetes Care
22.3.20.1. Overview
22.3.20.2. Product Portfolio
22.3.20.3. Sales Footprint
22.3.20.4. SWOT Analysis
22.3.20.5. Key Financials
22.3.20.6. Strategy Overview
22.3.21. Sanofi S.A.
22.3.21.1. Overview
22.3.21.2. Product Portfolio
22.3.21.3. Sales Footprint
22.3.21.4. SWOT Analysis
22.3.21.5. Key Financials
22.3.21.6. Strategy Overview
22.3.22. Companion Medical Inc.
22.3.22.1. Overview
22.3.22.2. Product Portfolio
22.3.22.3. Sales Footprint
22.3.22.4. SWOT Analysis
22.3.22.5. Key Financials
22.3.22.6. Strategy Overview
22.3.23. Ypsomed
22.3.23.1. Overview
22.3.23.2. Product Portfolio
22.3.23.3. Sales Footprint
22.3.23.4. SWOT Analysis
22.3.23.5. Key Financials
22.3.23.6. Strategy Overview
22.3.24. Hoffman - La Roche Ltd
22.3.24.1. Overview
22.3.24.2. Product Portfolio
22.3.24.3. Sales Footprint
22.3.24.4. SWOT Analysis
22.3.24.5. Key Financials
22.3.24.6. Strategy Overview
22.3.25. Novo Nordisk A/S
22.3.25.1. Overview
22.3.25.2. Product Portfolio
22.3.25.3. Sales Footprint
22.3.25.4. SWOT Analysis
22.3.25.5. Key Financials
22.3.25.6. Strategy Overview
22.3.26. Medtronic Plc.
22.3.26.1. Overview
22.3.26.2. Product Portfolio
22.3.26.3. Sales Footprint
22.3.26.4. SWOT Analysis
22.3.26.5. Key Financials
22.3.26.6. Strategy Overview
23. Assumptions and Acronyms Used24. Research Methodology
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
List of Tables
Table 01: Global Market Value (US$ Million) Analysis and Forecast 2014 to 2032, by Product
Table 02: Global Market Volume (Units) Analysis and Forecast 2014 to 2032, by Product
Table 03: Global Market Value (US$ Million) Analysis and Forecast 2014 to 2032, by Technology
Table 04: Global Market Value (US$ Million) Analysis and Forecast 2014 to 2032, by Distribution Channel
Table 05: Global Market Value (US$ Million) Analysis and Forecast 2014 to 2032, by Region
Table 06: North America Market Value (US$ Million) Analysis 2017 to 2021 and Forecast 2022 to 2032, by Country
Table 07: North America Market Value (US$ Million) Analysis and Forecast 2014 to 2032, by Product
Table 08: North America Market Volume (Units) Analysis and Forecast 2014 to 2032, by Product
Table 09: North America Market Value (US$ Million) Analysis and Forecast 2014 to 2032, by Technology
Table 10: North America Market Value (US$ Million) Analysis and Forecast 2014 to 2032, by Distribution Channel
Table 11: Latin America Market Value (US$ Million) Analysis 2017 to 2021 and Forecast 2022 to 2032, by Country
Table 12: Latin America Market Value (US$ Million) Analysis and Forecast 2014 to 2032, by Product
Table 13: Latin America Market Volume (Units) Analysis and Forecast 2014 to 2032, by Product
Table 14: Latin America Market Value (US$ Million) Analysis and Forecast 2014 to 2032, by Technology
Table 15: Latin America Market Value (US$ Million) Analysis and Forecast 2014 to 2032, by Distribution Channel
Table 16: Europe Market Value (US$ Million) Analysis 2017 to 2021 and Forecast 2022 to 2032, by Country
Table 17: Europe Market Value (US$ Million) Analysis and Forecast 2014 to 2032, by Product
Table 18: Europe Market Volume (Units) Analysis and Forecast 2014 to 2032, by Product
Table 19: Europe Market Value (US$ Million) Analysis and Forecast 2014 to 2032, by Technology
Table 20: Europe Market Value (US$ Million) Analysis and Forecast 2014 to 2032, by Distribution Channel
Table 21: South Asia Market Value (US$ Million) Analysis 2017 to 2021 and Forecast 2022 to 2032, by Country
Table 22: South Asia Market Value (US$ Million) Analysis and Forecast 2014 to 2032, by Product
Table 23: South Asia Market Volume (Units) Analysis and Forecast 2014 to 2032, by Product
Table 24: South Asia Market Value (US$ Million) Analysis and Forecast 2014 to 2032, by Technology
Table 25: South Asia Market Value (US$ Million) Analysis and Forecast 2014 to 2032, by Distribution Channel
Table 26: East Asia Market Value (US$ Million) Analysis 2017 to 2021 and Forecast 2022 to 2032, by Country
Table 27: East Asia Market Value (US$ Million) Analysis and Forecast 2014 to 2032, by Product
Table 28: East Asia Market Volume (Units) Analysis and Forecast 2014 to 2032, by Product
Table 29: East Asia Market Value (US$ Million) Analysis and Forecast 2014 to 2032, by Technology
Table 30: East Asia Market Value (US$ Million) Analysis and Forecast 2014 to 2032, by Distribution Channel
Table 31: Oceania Market Value (US$ Million) Analysis 2017 to 2021 and Forecast 2022 to 2032, by Country
Table 32: Oceania Market Value (US$ Million) Analysis and Forecast 2014 to 2032, by Product
Table 33: Oceania Market Volume (Units) Analysis and Forecast 2014 to 2032, by Product
Table 34: Oceania Market Value (US$ Million) Analysis and Forecast 2014 to 2032, by Technology
Table 35: Oceania Market Value (US$ Million) Analysis and Forecast 2014 to 2032, by Distribution Channel
Table 36: MEA Market Value (US$ Million) Analysis 2017 to 2021 and Forecast 2022 to 2032, by Country
Table 37: MEA Market Value (US$ Million) Analysis and Forecast 2014 to 2032, by Product
Table 38: MEA Market Volume (Units) Analysis and Forecast 2014 to 2032, by Product
Table 39: MEA Market Value (US$ Million) Analysis and Forecast 2014 to 2032, by Technology
Table 40: MEA Market Value (US$ Million) Analysis and Forecast 2014 to 2032, by Distribution Channel
Find your sweet spots for generating winning opportunities in this market.
List of Charts
Figure 01: Global Market Volume (Units), 2014 to 2021
Figure 02: Global Market Volume (Units) & Y-o-Y Growth (%) Analysis, 2022 to 2032
Figure 03: XYZ, Pricing Analysis per unit (US$), in 2022
Figure 04: XYZ, Pricing Forecast per unit (US$), in 2032
Figure 05: Global Market Value (US$ Million) Analysis, 2014 to 2021
Figure 06: Global Market Forecast & Y-o-Y Growth, 2022 to 2032
Figure 07: Global Market Absolute $ Opportunity (US$ Million) Analysis, 2021–2032
Figure 08: Global Market Value Share (%) Analysis 2022 and 2032, by Product
Figure 09: Global Market Y-o-Y Growth (%) Analysis 2021 to 2032, by Product
Figure 10: Global Market Attractiveness Analysis 2022 to 2032, by Product
Figure 11: Global Market Value Share (%) Analysis 2022 and 2032, by Technology
Figure 12: Global Market Y-o-Y Growth (%) Analysis 2021 to 2032, by Technology
Figure 13: Global Market Attractiveness Analysis 2022 to 2032, by Technology
Figure 14: Global Market Value Share (%) Analysis 2022 and 2032, by Distribution Channel
Figure 15: Global Market Y-o-Y Growth (%) Analysis 2021 to 2032, by Distribution Channel
Figure 16: Global Market Attractiveness Analysis 2022 to 2032, by Distribution Channel
Figure 17: Global Market Value Share (%) Analysis 2022 and 2032, by Region
Figure 18: Global Market Y-o-Y Growth (%) Analysis 2021 to 2032, by Region
Figure 19: Global Market Attractiveness Analysis 2022 to 2032, by Region
Figure 20: North America Market Value (US$ Million) Analysis, 2014 to 2021
Figure 21: North America Market Value (US$ Million) Forecast, 2022 to 2032
Figure 22: North America Market Value Share, by Product (2022 E)
Figure 23: North America Market Value Share, by Technology (2022 E)
Figure 24: North America Market Value Share, by Distribution Channel (2022 E)
Figure 25: North America Market Value Share, by Country (2022 E)
Figure 26: North America Market Attractiveness Analysis by Product, 2022 to 2032
Figure 27: North America Market Attractiveness Analysis by Technology, 2022 to 2032
Figure 28: North America Market Attractiveness Analysis by Distribution Channel, 2022 to 2032
Figure 29: North America Market Attractiveness Analysis by Country, 2022 to 2032
Figure 30: USA Market Value Proportion Analysis, 2021
Figure 31: Global Vs. USA Growth Comparison, 2021 to 2032
Figure 32: USA Market Share Analysis (%) by Product, 2021 & 2032
Figure 33: USA Market Share Analysis (%) by Technology, 2021 & 2032
Figure 34: USA Market Share Analysis (%) by Distribution Channel, 2021 & 2032
Figure 35: Canada Market Value Proportion Analysis, 2021
Figure 36: Global Vs. Canada. Growth Comparison, 2021 to 2032
Figure 37: Canada Market Share Analysis (%) by Product, 2021 & 2032
Figure 38: Canada Market Share Analysis (%) by Technology, 2021 & 2032
Figure 39: Canada Market Share Analysis (%) by Distribution Channel, 2021 & 2032
Figure 40: Latin America Market Value (US$ Million) Analysis, 2014 to 2021
Figure 41: Latin America Market Value (US$ Million) Forecast, 2022 to 2032
Figure 42: Latin America Market Value Share, by Product (2022 E)
Figure 43: Latin America Market Value Share, by Technology (2022 E)
Figure 44: Latin America Market Value Share, by Distribution Channel (2022 E)
Figure 45: Latin America Market Value Share, by Country (2022 E)
Figure 46: Latin America Market Attractiveness Analysis by Product, 2022 to 2032
Figure 47: Latin America Market Attractiveness Analysis by Technology, 2022 to 2032
Figure 48: Latin America Market Attractiveness Analysis by Distribution Channel, 2022 to 2032
Figure 49: Latin America Market Attractiveness Analysis by Country, 2022 to 2032
Figure 50: Mexico Market Value Proportion Analysis, 2021
Figure 51: Global Vs Mexico Growth Comparison, 2021 to 2032
Figure 52: Mexico Market Share Analysis (%) by Product, 2021 & 2032
Figure 53: Mexico Market Share Analysis (%) by Technology, 2021 & 2032
Figure 54: Mexico Market Share Analysis (%) by Distribution Channel, 2021 & 2032
Figure 55: Brazil Market Value Proportion Analysis, 2021
Figure 56: Global Vs. Brazil. Growth Comparison, 2021 to 2032
Figure 57: Brazil Market Share Analysis (%) by Product, 2021 & 2032
Figure 58: Brazil Market Share Analysis (%) by Technology, 2021 & 2032
Figure 59: Brazil Market Share Analysis (%) by Distribution Channel, 2021 & 2032
Figure 60: Argentina Market Value Proportion Analysis, 2021
Figure 61: Global Vs Argentina Growth Comparison, 2021 to 2032
Figure 62: Argentina Market Share Analysis (%) by Product, 2021 & 2032
Figure 63: Argentina Market Share Analysis (%) by Technology, 2021 & 2032
Figure 64: Argentina Market Share Analysis (%) by Distribution Channel, 2021 & 2032
Figure 65: Europe Market Value (US$ Million) Analysis, 2014 to 2021
Figure 66: Europe Market Value (US$ Million) Forecast, 2022 to 2032
Figure 67: Europe Market Value Share, by Product (2022 E)
Figure 68: Europe Market Value Share, by Technology (2022 E)
Figure 69: Europe Market Value Share, by Distribution Channel (2022 E)
Figure 70: Europe Market Value Share, by Country (2022 E)
Figure 71: Europe Market Attractiveness Analysis by Product, 2022 to 2032
Figure 72: Europe Market Attractiveness Analysis by Technology, 2022 to 2032
Figure 73: Europe Market Attractiveness Analysis by Distribution Channel, 2022 to 2032
Figure 74: Europe Market Attractiveness Analysis by Country, 2022 to 2032
Figure 75: United Kingdom Market Value Proportion Analysis, 2021
Figure 76: Global Vs. United Kingdom Growth Comparison, 2021 to 2032
Figure 77: United Kingdom Market Share Analysis (%) by Product, 2021 & 2032
Figure 78: United Kingdom Market Share Analysis (%) by Technology, 2021 & 2032
Figure 79: United Kingdom Market Share Analysis (%) by Distribution Channel, 2021 & 2032
Figure 80: Germany Market Value Proportion Analysis, 2021
Figure 81: Global Vs. Germany Growth Comparison, 2021 to 2032
Figure 82: Germany Market Share Analysis (%) by Product, 2021 & 2032
Figure 83: Germany Market Share Analysis (%) by Technology, 2021 & 2032
Figure 84: Germany Market Share Analysis (%) by Distribution Channel, 2021 & 2032
Figure 85: Italy Market Value Proportion Analysis, 2021
Figure 86: Global Vs. Italy Growth Comparison, 2021 to 2032
Figure 87: Italy Market Share Analysis (%) by Product, 2021 & 2032
Figure 88: Italy Market Share Analysis (%) by Technology, 2021 & 2032
Figure 89: Italy Market Share Analysis (%) by Distribution Channel, 2021 & 2032
Figure 90: France Market Value Proportion Analysis, 2021
Figure 91: Global Vs France Growth Comparison, 2021 to 2032
Figure 92: France Market Share Analysis (%) by Product, 2021 & 2032
Figure 93: France Market Share Analysis (%) by Technology, 2021 & 2032
Figure 94: France Market Share Analysis (%) by Distribution Channel, 2021 & 2032
Figure 95: Spain Market Value Proportion Analysis, 2021
Figure 96: Global Vs Spain Growth Comparison, 2021 to 2032
Figure 97: Spain Market Share Analysis (%) by Product, 2021 & 2032
Figure 98: Spain Market Share Analysis (%) by Technology, 2021 & 2032
Figure 99: Spain Market Share Analysis (%) by Distribution Channel, 2021 & 2032
Figure 100: Russia Market Value Proportion Analysis, 2021
Figure 101: Global Vs Russia Growth Comparison, 2021 to 2032
Figure 102: Russia Market Share Analysis (%) by Product, 2021 & 2032
Figure 103: Russia Market Share Analysis (%) by Technology, 2021 & 2032
Figure 104: Russia Market Share Analysis (%) by Distribution Channel, 2021 & 2032
Figure 105: BENELUX Market Value Proportion Analysis, 2021
Figure 106: Global Vs BENELUX Growth Comparison, 2021 to 2032
Figure 107: BENELUX Market Share Analysis (%) by Product, 2021 & 2032
Figure 108: BENELUX Market Share Analysis (%) by Technology, 2021 & 2032
Figure 109: BENELUX Market Share Analysis (%) by Distribution Channel, 2021 & 2032
Figure 110: East Asia Market Value (US$ Million) Analysis, 2014 to 2021
Figure 111: East Asia Market Value (US$ Million) Forecast, 2022 to 2032
Figure 112: East Asia Market Value Share, by Product (2022 E)
Figure 113: East Asia Market Value Share, by Technology (2022 E)
Figure 114: East Asia Market Value Share, by Distribution Channel (2022 E)
Figure 115: East Asia Market Value Share, by Country (2022 E)
Figure 116: East Asia Market Attractiveness Analysis by Product, 2022 to 2032
Figure 117: East Asia Market Attractiveness Analysis by Technology, 2022 to 2032
Figure 118: East Asia Market Attractiveness Analysis by Distribution Channel, 2022 to 2032
Figure 119: East Asia Market Attractiveness Analysis by Country, 2022 to 2032
Figure 120: China Market Value Proportion Analysis, 2021
Figure 121: Global Vs. China Growth Comparison, 2021 to 2032
Figure 122: China Market Share Analysis (%) by Product, 2021 & 2032
Figure 123: China Market Share Analysis (%) by Technology, 2021 & 2032
Figure 124: China Market Share Analysis (%) by Distribution Channel, 2021 & 2032
Figure 125: Japan Market Value Proportion Analysis, 2021
Figure 126: Global Vs. Japan Growth Comparison, 2021 to 2032
Figure 127: Japan Market Share Analysis (%) by Product, 2021 & 2032
Figure 128: Japan Market Share Analysis (%) by Technology, 2021 & 2032
Figure 129: Japan Market Share Analysis (%) by Distribution Channel, 2021 & 2032
Figure 130: South Korea Market Value Proportion Analysis, 2021
Figure 131: Global Vs South Korea Growth Comparison, 2021 to 2032
Figure 132: South Korea Market Share Analysis (%) by Product, 2021 & 2032
Figure 133: South Korea Market Share Analysis (%) by Technology, 2021 & 2032
Figure 134: South Korea Market Share Analysis (%) by Distribution Channel, 2021 & 2032
Figure 135: South Asia Market Value (US$ Million) Analysis, 2014 to 2021
Figure 136: South Asia Market Value (US$ Million) Forecast, 2022 to 2032
Figure 137: South Asia Market Value Share, by Product (2022 E)
Figure 138: South Asia Market Value Share, by Technology (2022 E)
Figure 139: South Asia Market Value Share, by Distribution Channel (2022 E)
Figure 140: South Asia Market Value Share, by Country (2022 E)
Figure 141: South Asia Market Attractiveness Analysis by Product, 2022 to 2032
Figure 142: South Asia Market Attractiveness Analysis by Technology, 2022 to 2032
Figure 143: South Asia Market Attractiveness Analysis by Distribution Channel, 2022 to 2032
Figure 144: South Asia Market Attractiveness Analysis by Country, 2022 to 2032
Figure 145: India Market Value Proportion Analysis, 2021
Figure 146: Global Vs. India Growth Comparison, 2021 to 2032
Figure 147: India Market Share Analysis (%) by Product, 2021 & 2032
Figure 148: India Market Share Analysis (%) by Technology, 2021 & 2032
Figure 149: India Market Share Analysis (%) by Distribution Channel, 2021 & 2032
Figure 150: Indonesia Market Value Proportion Analysis, 2021
Figure 151: Global Vs. Indonesia Growth Comparison, 2021 to 2032
Figure 152: Indonesia Market Share Analysis (%) by Product, 2021 & 2032
Figure 153: Indonesia Market Share Analysis (%) by Technology, 2021 & 2032
Figure 154: Indonesia Market Share Analysis (%) by Distribution Channel, 2021 & 2032
Figure 155: Malaysia Market Value Proportion Analysis, 2021
Figure 156: Global Vs. Malaysia Growth Comparison, 2021 to 2032
Figure 157: Malaysia Market Share Analysis (%) by Product, 2021 & 2032
Figure 158: Malaysia Market Share Analysis (%) by Technology, 2021 & 2032
Figure 159: Malaysia Market Share Analysis (%) by Distribution Channel, 2021 & 2032
Figure 160: Thailand Market Value Proportion Analysis, 2021
Figure 161: Global Vs. Thailand Growth Comparison, 2021 to 2032
Figure 162: Thailand Market Share Analysis (%) by Product, 2021 & 2032
Figure 163: Thailand Market Share Analysis (%) by Technology, 2021 & 2032
Figure 164: Thailand Market Share Analysis (%) by Distribution Channel, 2021 & 2032
Figure 165: Oceania Market Value (US$ Million) Analysis, 2014 to 2021
Figure 166: Oceania Market Value (US$ Million) Forecast, 2022 to 2032
Figure 167: Oceania Market Value Share, by Product (2022 E)
Figure 168: Oceania Market Value Share, by Technology (2022 E)
Figure 169: Oceania Market Value Share, by Distribution Channel (2022 E)
Figure 170: Oceania Market Value Share, by Country (2022 E)
Figure 171: Oceania Market Attractiveness Analysis by Product, 2022 to 2032
Figure 172: Oceania Market Attractiveness Analysis by Technology, 2022 to 2032
Figure 173: Oceania Market Attractiveness Analysis by Distribution Channel, 2022 to 2032
Figure 174: Oceania Market Attractiveness Analysis by Country, 2022 to 2032
Figure 175: Australia Market Value Proportion Analysis, 2021
Figure 176: Global Vs. Australia Growth Comparison, 2021 to 2032
Figure 177: Australia Market Share Analysis (%) by Product, 2021 & 2032
Figure 178: Australia Market Share Analysis (%) by Technology, 2021 & 2032
Figure 179: Australia Market Share Analysis (%) by Distribution Channel, 2021 & 2032
Figure 180: New Zealand Market Value Proportion Analysis, 2021
Figure 181: Global Vs New Zealand Growth Comparison, 2021 to 2032
Figure 182: New Zealand Market Share Analysis (%) by Product, 2021 & 2032
Figure 183: New Zealand Market Share Analysis (%) by Technology, 2021 & 2032
Figure 184: New Zealand Market Share Analysis (%) by Distribution Channel, 2021 & 2032
Figure 185: Middle East & Africa Market Value (US$ Million) Analysis, 2014 to 2021
Figure 186: Middle East & Africa Market Value (US$ Million) Forecast, 2022 to 2032
Figure 187: Middle East & Africa Market Value Share, by Product (2022 E)
Figure 188: Middle East & Africa Market Value Share, by Technology (2022 E)
Figure 189: Middle East & Africa Market Value Share, by Distribution Channel (2022 E)
Figure 190: Middle East & Africa Market Value Share, by Country (2022 E)
Figure 191: Middle East & Africa Market Attractiveness Analysis by Product, 2022 to 2032
Figure 192: Middle East & Africa Market Attractiveness Analysis by Technology, 2022 to 2032
Figure 193: Middle East & Africa Market Attractiveness Analysis by Distribution Channel, 2022 to 2032
Figure 194: Middle East & Africa Market Attractiveness Analysis by Country, 2022 to 2032
Figure 195: GCC Countries Market Value Proportion Analysis, 2021
Figure 196: Global Vs GCC Countries Growth Comparison, 2021 to 2032
Figure 197: GCC Countries Market Share Analysis (%) by Product, 2021 & 2032
Figure 198: GCC Countries Market Share Analysis (%) by Technology, 2021 & 2032
Figure 199: GCC Countries Market Share Analysis (%) by Distribution Channel, 2021 & 2032
Figure 200: Turkey Market Value Proportion Analysis, 2021
Figure 201: Global Vs. Turkey Growth Comparison, 2021 to 2032
Figure 202: Turkey Market Share Analysis (%) by Product, 2021 & 2032
Figure 203: Turkey Market Share Analysis (%) by Technology, 2021 & 2032
Figure 204: Turkey Market Share Analysis (%) by Distribution Channel, 2021 & 2032
Figure 205: South Africa Market Value Proportion Analysis, 2021
Figure 206: Global Vs. South Africa Growth Comparison, 2021 to 2032
Figure 207: South Africa Market Share Analysis (%) by Product, 2021 & 2032
Figure 208: South Africa Market Share Analysis (%) by Technology, 2021 & 2032
Figure 209: South Africa Market Share Analysis (%) by Distribution Channel, 2021 & 2032
Figure 210: North Africa Market Value Proportion Analysis, 2021
Figure 211: Global Vs North Africa Growth Comparison, 2021 to 2032
Figure 212: North Africa Market Share Analysis (%) by Product, 2021 & 2032
Figure 213: North Africa Market Share Analysis (%) by Technology, 2021 & 2032
Figure 214: North Africa Market Share Analysis (%) by Distribution Channel, 2021 & 2032
